Drugs / IBC-VS01
last change Jun 2010 re-read 3 minutes ago

IBC-VS01

also known as human insulin B-chain

Vaccine

Developed for
type 1 diabetes mellitus
Investigated by
Immune Tolerance Network (ITN) · National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00057499 Mar 2003 → Mar 2007 type 1 diabetes mellitus National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as IBC-VS01 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00057499 ↗
Known as human insulin B-chain “The study drug, human insulin B-chain in incomplete Freund's adjuvant (IFA) was administered as a single intramuscular injection” PMID 19931408 ↗ Jun 2010
Modality Vaccine “an insulin-based vaccine” NCT00057499 ↗
Route Intramuscular “The study drug, human insulin B-chain in incomplete Freund's adjuvant (IFA) was administered as a single intramuscular injection” PMID 19931408 ↗ Jun 2010